New hope for accurate prognosis of prostate and blood cancers using 3D telomeric imaging and Lamin A/C

Genetic mutations are known to be a factor in the development of cancer.

Professor Sabine Mai of the University of Manitoba, Canada, has been examining the links between genomic instability and cancer using 3D imaging of the genome. She has also collaborated on cutting-edge research, utilising a potential biomarker called Lamin A/C for determining the aggressiveness of Hodgkin’s lymphoma and the severity of Multiple Myeloma. This research is a first step toward circumventing […]

Read More…

A new generation of induced pluripotent stem cells for regenerative medicine

Dr Schrepfer and Dr Deuse conducting their stem cell research

Embryonic stem cells or induced pluripotent stem cells are unlimited sources for the generation of cell derivatives for the regeneration of failing organs. However, such cell transplants are subject to immune rejection by the recipient’s immune system. Drs Sonja Schrepfer and Tobias Deuse from the University of California, San Francisco, have developed a new generation of immune-edited induced pluripotent stem […]

Read More…

Tracking how SARS-CoV-2 mutates around the world during COVID-19 pandemic

Tracking how SARS-CoV-2 mutates around the world during COVID-19 pandemic

The COVID-19 pandemic is an ongoing global health crisis caused by the SARS-CoV-2 strain of coronavirus. The SARS-CoV-2 virus mutates as it spreads, and monitoring these mutations and their distribution could provide information relevant for the treatment and control of the disease. Santiago Justo Arévalo (Ricardo Palma University, Peru) and his colleagues have analysed the progress of several mutations across […]

Read More…

Thank you for expressing interest in joining our mailing list and community. Below you can select how you’d like us to interact with you and we’ll keep you updated with our latest content.

You can change your preferences or unsubscribe by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at at any time and if you have any questions about how we handle your data, please review our privacy agreement.

Would you like to learn more about our services?

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.

Subscribe to our FREE PUBLICATION